Crossmark

Low-dose abiraterone acetate for the treatment of prostate cancer: An observational cohort study

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.06.012

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Di-Giuseppe, Luis Angel

Ramirez-Murillo, Rodney Alexander

Aymar, Mariano Daniel

Basbus, Luis Roberto

Cornec, Milagros

Terrasa, Sergio Adrián

Posadas-Martínez, Maria Lourdes

Burgos, Mariana Andrea

Buela, Gabriela

Cayol, Federico
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

Version of Record valid from 2025-06-18
More Information

This article is maintained by: Elsevier

Article Title: Low-dose abiraterone acetate for the treatment of prostate cancer: An observational cohort study

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.06.012

Content Type: article

Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).